FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372481008: Skin anti-infective (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197774010 Skin anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211016014 Skin anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1197774010 Skin anti-infective (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1197774010 Skin anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211016014 Skin anti-infective en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211016014 Skin anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    189931000077110 anti-infectieux cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
    189931000077110 anti-infectieux cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    anti-infectieux cutané Is a Local anti-infective false Inferred relationship Existential restriction modifier (core metadata concept)
    anti-infectieux cutané Is a Anti-infective agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    anti-infectieux cutané Is a agent cutané false Inferred relationship Existential restriction modifier (core metadata concept)
    anti-infectieux cutané Is a agent topique cutané false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + polymyxin b 5mg/10000unt drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin b sulfate + trimethoprim sulfate 10000unt/ns solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Neo-tabs 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Mycifradin 125mg/5mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Neo-fradin 125mg/5mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin b sulfate + trimethoprim sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Colistin sulfate + hydrocortisone acetate + neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    médicament contenant dexaméthasone et néomycine et polymyxine B The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Cetylpyridinium chloride+ ascorbic acid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing dexamethasone sodium phosphate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + polymyxin b sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate+neomycin sulfate+Nystatin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Medicinal product containing cyclic lipopeptide and acting as antibacterial agent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing daptomycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin 0.5% ear drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Daptomycin 250mg injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Daptomycin 500 mg injection solution 10 mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Lidocaine- and neomycin- and polymyxin B-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing neomycin and polymyxin B and pramocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing neomycin and polymyxin B (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorhexidine hydrochloride+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clobetasone butyrate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Iodophore (substance) Is a False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing chlorocresol and potassium hydroxyquinoline sulfate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Chlorocresol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing cetylpyridinium and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone- and neomycin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone- and neomycin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing neomycin and triamcinolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Polymyxin B- and trimethoprim-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing bacitracin and polymyxin B (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing cetylpyridinium and guaifenesin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing cetylpyridinium and menthol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Mercuric oxide Is a False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Carbol-fuchsin topical solution Is a False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Halquinol Is a False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Undecoylium chloride iodine Is a False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium meralein Is a False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Local anti-infective and anti-inflammatory poisoning Causative agent (attribute) False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)
    Poisoning caused by local anti-infective Causative agent (attribute) False anti-infectieux cutané Inferred relationship Existential restriction modifier (core metadata concept)

    Start Page 2 of 2

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start